Eye drop trial aims to halt worsening vision in kids
Disease control
Recruiting now
This study is testing whether low-dose atropine eye drops can safely slow the progression of nearsightedness in children. Researchers will compare the drops to a placebo in 144 children aged 5-10 over two years. The goal is to find a treatment that can help control worsening visi…
Phase: PHASE3 • Sponsor: IDB VisionCare SDN BHD • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC